12885_2020_7100_MOESM7_ESM.xlsx (101.91 kB)
Additional file 7 of Candidate methylation sites associated with endocrine therapy resistance in ER+/HER2- breast cancer
dataset
posted on 2020-07-20, 04:05 authored by Maryam Soleimani Dodaran, Simone Borgoni, Emre Sofyalı, Pernette J. Verschure, Stefan Wiemann, Perry D. Moerland, Antoine H. C. van KampenAdditional file 7. Multi-locus survival analysis. Results of multi-locus survival analysis on ER+/HER2-, TAM and AI cohorts. For each CpG the results of the correlation analysis and of the differential methylation analysis of month 7 versus WT in the T47D RA experiment are also included.